
APREA THERAPEUTICS INC
APRE · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $0.64
- Today’s Low
- $0.59
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.61
- Previous Close
- $0.59
- Volume
- 117.52K
- Market Cap
- $7.46M
- P/E Ratio
- --
- EPS
- $-1.07
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, UNITED STATES, 18902
- Country
- US
- Listing Date
- 2019-10-03
- Fiscal Year End
- December
- Shares Outstanding
- 12.38M
- CIK
- 0001781983
- Website
- www.aprea.com
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor protein. The company is headquartered in Boston, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$3.33K
2025-09-30
$1.84K
Operating Expenses
2026-06-30
$4.03M
2026-03-31
$3.42M
2025-12-31
$2.64M
2025-09-30
$3.11M
Net Income
2026-06-30
-$3.59M
2026-03-31
-$3.28M
2025-12-31
-$2.45M
2025-09-30
-$2.97M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
-73.58K%
2025-09-30
-160.84K%
Earnings Per Share
2026-06-30
$-0.07
2026-03-31
$-0.22
2025-12-31
$-0.32
2025-09-30
$-0.47
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.58M
2026-03-31
-$3.28M
2025-12-31
-$2.45M
2025-09-30
-$2.96M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $3.33K | $1.84K |
| Operating Expenses | $4.03M | $3.42M | $2.64M | $3.11M |
| Net Income | -$3.59M | -$3.28M | -$2.45M | -$2.97M |
| Net Profit Margin | -- | -- | -73.58K% | -160.84K% |
| Earnings Per Share | $-0.07 | $-0.22 | $-0.32 | $-0.47 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.58M | -$3.28M | -$2.45M | -$2.96M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.